tirzepatide and bimagrumab Antibody blockade of activin type II receptors preserves skeletal muscle mass enhances fat loss during GLP-1 receptor agonism Bimagrumab + Tirzepatide for Obesity

Description

If your compounding pharmacy or provider gives you a choice, consider where you are in the titration schedule

Severe nausea or vomiting affecting meal tolerance warrants dose adjustment or temporary stabilization

What should I do immediately

Both are excellent once weekly injections, but they work slightly differently. Mounjaro acts on two hormones (GLP1 and GIP) and showed an average 22.5% weight loss in trials. Wegovy works on GLP1 alone, with an average 15% weight loss. Mounjaro starts from 164.99 a month and Wegovy from 99.99. Your clinician will help you decide which is the better fit based on your goals, medical history, and budget

When patients stop tirzepatide, weight comes back for the majority not because they are doing anything wrong, but because the biological environment that drives weight regain is restored when the medication is removed